Press Releases, News Articles and Statements from Our Leadership Team
|Nephria Bio presents at Medinvest Medtech, Digital Health and AI Conference, Virtual June 23-25, 2021|
Nephria Bio, a company founded with the goal of reimagining the dialysis process, will present at the Medinvest Medtech, Digital Health and AI Conference this June, held virtually. Nephria Bio plans to present on its groundbreaking dialysis technology, including its current development of a more efficient and effective dialyzer and a wearable dialysis solution, the EOCARRT. Nephria Bio’s cofounder Jesse Kim will be presenting on the company’s important advances in the field of dialysis, and will explain Nephria Bio’s vision of bringing enhanced dignity and freedom to the lives of hundreds of thousands of dialysis users in the United States and worldwide.
Nephria Bio Signs Exclusive Agreement with Drexel University to license new “MXene” nanomaterial for future dialysis innovations https://www.prnewswire.com/news-releases/nephria-bio-signs-exclusive-agreement-with-drexel-university-to-license-new-mxene-nanomaterial-for-future-dialysis-innovations-301279812.htm
Any devices mentioned on this website that are not explicitly indicated as a wellness device are investigative devices only and not available for commercial human use in any jurisdiction. Neither device has received FDA clearance or approval and neither has received CE mark or other competent authority licensure. All images are projected product configuration, final dimensions and features may vary. Any financial projections are predictions only and not guarantees of future return on investment.